Category: 112-63-0

Casale, Elena; Amboldi, Nadia; Brasca, Maria Gabriella; Caronni, Dannica; Colombo, Nicoletta; Dalvit, Claudio; Felder, Eduard R.; Fogliatto, Gianpaolo; Galvani, Arturo; Isacchi, Antonella; Polucci, Paolo; Riceputi, Laura; Sola, Francesco; Visco, Carlo; Zuccotto, Fabio; Casuscelli, Francesco published the artcile< Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors>, Electric Literature of 112-63-0, the main research area is aminotriazoloquinazoline preparation heat shock protein inhibitor; Anti-cancer agents; FAXS-NMR screening; Fragment based hit discovery; Hsp90 inhibitors; Structure-based design.

In the last decade the heat shock protein 90 (Hsp90) has emerged as a major therapeutic target and many efforts have been dedicated to the discovery of Hsp90 inhibitors as new potent anticancer agents. Here the authors report the identification of a novel class of Hsp90 inhibitors by means of a biophys. FAXS-NMR based screening of a library of fragments. The use of x-ray structure information combined with modeling studies enabled the fragment evolution of the initial triazoloquinazoline hit to a class of compounds with nanomolar potency and drug-like properties suited for further lead optimization.

Bioorganic & Medicinal Chemistry published new progress about Antitumor agents. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Electric Literature of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Wang, Haili; Li, Chuchu; Liu, Xiaoqing; Ma, Mingliang published the artcile< Design, synthesis and activity study of a novel PI3K degradation by hijacking VHL E3 ubiquitin ligase>, Product Details of C19H34O2, the main research area is PROTAC PI3K kinase Von Hippel Lindau degradation agent preparation; Degradation; PI3K; PROTAC; VHL.

PI3K kinase plays an important role in regulating key processes in cells, such as cell growth, metabolism, proliferation, and apoptosis. The overexpression of PI3K kinase exists in many cancers. The proteolytic target chimera (PROTAC) technol. is a new technol. that uses the ubiquitin-proteasome system to degrade a given target protein. It has been described that CRBN-based PROTAC targets the degradation of PI3K kinase. However, PROTAC based on VHL has not been reported yet. Here, the previously obtained highly active PI3K inhibitor was connected to the VHL ligand through different small mols., and obtained a series of PROTAC mols. targeting PI3K kinase. Obtain the most active compound through screening. It provides evidence for the feasibility of PROTAC technol. to recruit VHL E3 ligase in PI3K kinase.

Bioorganic & Medicinal Chemistry published new progress about Antitumor agents. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Product Details of C19H34O2.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Wang, Bin; Liu, Bin; Luo, Qing; Sun, Ding; Li, Hao; Zhang, Jie; Jin, Xinye; Cheng, Xiaowei; Niu, Jingxue; Yuan, Qing; Chen, Yizhi published the artcile< PANK1 associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database>, Recommanded Product: (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is renal cell carcinoma PANK1 cancer metabolism immune infiltration; Clear cell renal cell carcinoma (ccRCC); immune infiltration; pantothenate kinase-1; promoter methylation; tumor metabolism.

Identify key biomarkers to improve the clin. prognosis of patients with advanced and metastatic clear cell renal cell carcinoma (ccRCC) remains an important research topic. Recently, ccRCC has been regarded as a metabolic disease. Pantothenate kinase-1 (PANK1) has been shown to play an important regulatory role in global metabolism and associates with the pathogenesis of hepatocellular carcinoma. Therefore, we aimed to investigate the role of PANK1 in the prognosis of ccRCC and in metabolism and immunity. PANK1 mRNA (RNA) expression patterns in ccRCC using The Cancer Genome Atlas (TCGA) database. The clin. prognostic significance of PANK1 in ccRCC and a Cox regression was performed to evaluate the clin. factors associated with prognosis with confounding factors adjusted. The signaling pathways related to PANK1 expression were identified by Gene Ontol. (GO) investigation and Kyoto Encyclopedia of Genes and Genomes (KEGG) anal. The Tumor Immune Estimation Resource database was used to analyze the correlation between PANK1 and tumor-infiltrating immune cells. A total of 539 ccRCC patients and corresponding clin. samples and data from TCGA were included in this anal. Significant differences were observed in PANK1 expression levels between tumor tissues and adjacent normal tissues in both TCGA-Kidney Renal Clear Cell Carcinoma cohort (4.40 vs.2.94, P<0.001). PANK1 expression was found to be correlated with pathol. stage, histol. grade, age, sex, and clin. prognosis. Specifically, the low expression of PANK1 was found to be closely related to poor overall survival (OS), disease-specific survival (DSS), and the progression-free survival (PFS) in ccRCC patients. The receiver operating characteristic curve suggested that PANK1 could be a potential prognostic biomarker (area under the curve =0.880), and that the promoter methylation levels of PANK1 were correlated with clin. factors. Further, PANK1 expression was found to be associated with multiple immune cell types and correlated with the enrichment of these cells. Finally, we further investigated the role of PANK1 in tumor growth and mitochondrial metabolism using ccRCC cells. PANK1 correlates with ccRCC prognosis, tumor immune status and metabolism using the TCGA data. PANK1 might be a prognostic marker of clin. prognosis for ccRCC patients. Translational Cancer Research published new progress about Acute myeloid leukemia. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Recommanded Product: (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Omuro, Antonio published the artcile< Immune-checkpoint inhibitors for glioblastoma: what have we learned?>, Electric Literature of 112-63-0, the main research area is .

BACKGROUND: Glioblastoma, the most common malignant primary brain tumor, remains a lethal disease with few therapeutic options. Immunotherapies, particularly immune checkpoint inhibitors (ICPi), have revolutionized cancer treatment, but their role in glioblastoma is uncertain. OBJECTIVE: To review the state of immunotherapies in glioblastoma, with an emphasis on recently published ICPi clinical trials. METHODS: In this editorial/opinion article, we critically review results of the first generation of trials of ipilimumab, nivolumab and pembrolizumab in glioblastoma, as well as future directions. RESULTS: Expression of PD-L1 is frequent in glioblastoma, ranging from 60-70% of patients. Phase 1 studies of nivolumab with and without ipilimumab, as well as pembrolizumab, showed no new safety concerns in brain tumors, and no neurotoxicity. However, randomized phase 3 trials of nivolumab showed no survival improvements over bevacizumab in recurrent glioblastoma; no role in newly diagnosed disease as a replacement for temozolomide in unmethylated MGMT promoter tumors; and no benefit as an addition to temozolomide in methylated MGMT tumors. However, studies examining post treatment tumor samples have shown signs of increased immunologic response, and occasional long lasting radiographic responses have been seen. A small study of pembrolizumab suggested a potential role as a “”neoadjuvant”” treatment in resectable recurrent glioblastoma, while other studies are investigating selection of patients with higher mutational burden and novel agents and combinatorial strategies. CONCLUSION: Despite initial negative trials, immunotherapy remains of high interest in glioblastoma, and many trials are still ongoing. Improving our mechanistic understanding of the immunosuppression and T cell dysfunction induced by both tumor and the CNS microenvironment remains however crucial for the development of successful immunotherapeutic approaches in this disease.

Arquivos de neuro-psiquiatria published new progress about 112-63-0. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Electric Literature of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Yu, Min; Wu, Xuecheng; Wang, Jingjing; He, Mengyu; Han, Honghao; Hu, Song; Xu, Jian; Yang, Mingxia; Tan, Qi; Wang, Yanli; Wang, Hong; Xie, Weiping; Kong, Hui published the artcile< Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-魏B pathways>, Application In Synthesis of 112-63-0, the main research area is endothelial-to-mesenchymal transition; monocrotaline; paeoniflorin; pulmonary arterial hypertension; pulmonary vascular remodeling; smooth muscle cells.

Pulmonary arterial hypertension (PAH) characterized by pulmonary vascular remodeling is a lethal disease. Paeoniflorin (PF) is a monoterpene glycoside with numerous beneficial functions, such as vasodilation, anti-inflammation and immunomodulation. This study aims to investigate the effects of PF on monocrotaline (MCT)-induced PAH rats. Our data showed that both prophylactic or therapeutic administration of PF alleviated MCT-induced increasing of right ventricular systolic pressure (RVSP), prevented right ventricle hypertrophy and pulmonary arterial remodeling, as well as inhibited inflammatory cell infiltration around pulmonary arteries. Meanwhile, PF blocked MCT-induced endothelial-mesenchymal transition (EndMT) as indicated by the restored expression of endothelial markers in lung. Moreover, PF inhibited MCT-induced down-regulation of bone morphogenetic protein receptor 2 (BMPR2) and suppressed MCT-induced phosphorylation of transforming growth factor-�(TGF� activated kinase 1 (TAK1) in vivo. In vitro studies indicated that PF prevented human pulmonary arterial smooth muscle cells (PASMCs) from platelet-derived growth factor-BB (PDGF-BB)-stimulated proliferation and migration. PF also partially reversed TGF�, interleukin-1�(IL-1� and tumor necrosis factor (TNF-� co-stimulated endothelial-to-mesenchymal transition (EndMT) in cultured human pulmonary artery endothelial cells (HPAECs). Signaling pathway anal. demonstrated that the underlying mechanism might be associated with the inhibition of TAK1-MAPK/NF-魏B pathways. Taken together, our results suggested that PF could be a potential drug for the treatment of PAH.

International Journal of Medical Sciences published new progress about 112-63-0. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application In Synthesis of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Sayama, Shinsei published the artcile< Direct conversion of aromatic 1,3-dioxanes to hydroxypropyl esters with pyridinium hydrobromide perbromide and sodium acetate in water>, Related Products of 112-63-0, the main research area is hydorxypropyl ester preparation; dioxane reactant pyridinium hydrobromide perbromide reagent hydorxypropyl ester preparation.

Various aromatic 1,3-dioxanes were directly converted to resp. hydorxypropyl esters I [R = 4-MeC6H4, 2-ClC6H4, (CH2)2C6H4, etc.] with pyridinium hydrobromide perbromide and sodium acetate in water at room temperature

Heterocycles published new progress about Dioxanes Role: RCT (Reactant), RACT (Reactant or Reagent). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Related Products of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Ourhzif, El-Mahdi; Paris, Arnaud; Abrunhosa-Thomas, Isabelle; Ketatni, El Mostafa; Chalard, Pierre; Khouili, Mostafa; Daniellou, Richard; Troin, Yves; Akssira, Mohamed published the artcile< Design, synthesis, and evaluation of cytotoxic activities of arylnaphthalene lignans and aza-analogs>, Quality Control of 112-63-0, the main research area is lung cancer glioma melanoma justicidin C cytotoxicity antitumor; arylnaphthalene lactones; aza-arylnaphthalene lignans; cytotoxic activity; justicidin C; methoxy-vitedoamine A; retrojusticidin B; substituted naphthols.

A concise and versatile synthetic strategy for the total synthesis of arylnaphthalene lignans and aza-analogs was developed. The main objective was to develop synthetic tactics for the creation of the lactone and lactam unit that would give access to an array of synthetic, natural, and/or bioactive compounds through rather simple chem. manipulation. The flexibility and potentiality of these new processes were further illustrated by the total synthesis of retrojusticidin B (13b), justicidin C (14b), and methoxy-vitedoamine A (22a). In this study, a series of novel aryl-naphthalene lignans and aza-analogs were synthesized, and the cytotoxic activities of all compounds on cancer cell growth were evaluated. The target compounds were structurally characterized by 1H NMR (NMR), 13C NMR, IR, high-resolution mass spectrometry, and X-ray crystallog. The IC50 values of these compounds on five tumor cell lines (A549, HS683, MCF-7, SK-MEL-28, and B16-F1) were obtained by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) colorimetric assay. Five of the compounds exhibited excellent activity compared to 5-fluorouracil and etoposide against the five cell lines tested, with IC50 values ranging from 1 to 10渭M.

Archiv der Pharmazie (Weinheim, Germany) published new progress about Antitumor agents. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Quality Control of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Dall’Argine, Corrado; Hochwallner, Alexander; Klikovits, Nicolas; Liska, Robert; Stampf, Juergen; Sangermano, Marco published the artcile< Hot-Lithography SLA-3D Printing of Epoxy Resin>, Product Details of C19H34O2, the main research area is cationic photopolymerized epoxy resin three dimensional printing.

The hot-lithog. stereolithog. 3D printing technol. is used to print epoxy resins with high reactivity in order to achieve 3D printed structures. Different hydroxyl containing compounds are investigated as chain transfer agents and the viscoelastic properties of UV-cured materials are fully characterized. The most promising formulations are studied at a high temperature, the 3D printing process parameters are defined and the printed object is fully characterized. By combining the suitable precursor materials in the photocurable formulation with the advanced hot-lithog. process, it is possible to produce 3D printed structures that are characterized by outstanding thermomech. properties and good printability precision.

Macromolecular Materials and Engineering published new progress about Cationic photopolymerization. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Product Details of C19H34O2.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Fava, Eleonora; Nakajima, Masaki; Tabak, Martin B.; Rueping, Magnus published the artcile< Tin-free visible light photoredox catalyzed cyclization of enamides as a mild procedure for the synthesis of �lactams>, Quality Control of 112-63-0, the main research area is chloroenamide iridium catalyst photoredox cyclization; lactam diastereoselective preparation green chem.

The visible light mediated tin-free cyclization of �chloroenamides led to the synthesis of substituted �lactams with excellent stereoselectivity was reported. The protocol employed the single-electron reduction of activated C-Cl bonds, which were typically inert towards reduction

Green Chemistry published new progress about Cyclization catalysts, stereoselective (photoredox). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Quality Control of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Vaultier, Michel; Carrie, Robert published the artcile< Formation of a 1,2,4-oxadiazoline from an aziridine: mechanism of the reaction and photochemical conversion into a benzimidazole derivative>, Application of C19H34O2, the main research area is aziridinedicarboxylate cleavage nitrite; phenylaziridinedicarboxylate cleavage nitrite; rearrangement photolysis phenyloxadiazoline; oxadiazoline phenyl rearrangement benzimidazole; benzimidazolecarboxylate.

Reaction of NaNO2 with the aziridine I in the presence of BzOH gave 75% oxadiazoline II, which on photolysis in C6H6 gave 86% benzimidazole III. The formation of II probably involved addition of NaNO2 to PhCH:N+PhCH(CO2Me)2 BzO-, followed by cyclization, and demethoxycarbonylation by a å°?lactam path.

Journal of the Chemical Society, Chemical Communications published new progress about Photorearrangement. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application of C19H34O2.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics